(PRWEB) May 06, 2013
Diagnostics Research Group, an independent site for pharmaceutical and device research, is working with pharmaceutical companies to assess osteoarthritis (OA) medications currently not available to the public.
Osteoarthritis is the most common form of arthritis and affects an estimated 27 million Americans. OA occurs when a joint’s cartilage breaks down. The absence of cartilage causes bones to rub against each other, which then can lead to stiffness, pain and loss of movement in the joint.
There are many contributing factors that may cause a person to develop OA. One of the most common causes for OA, especially in knees, is obesity. According to the Arthritis Foundation, “for every pound a person gains, they also add four pounds of pressure on their knees and six times the pressure on their hips.” A person’s age can have an effect on their joints, as well as an injury or overuse of the joint. Other risk factors can be muscle weakness or simply genetics.
Dr. Charles Andrews, Director of Clinical Research at Diagnostics Research Group notes that “with 70 million baby boomers in the U.S., there is a great need for innovative treatments of OA.”
Common symptoms include: joint soreness, stiffness, increasing pain throughout the day and the loss of coordination, posture and walking due to pain and stiffness. To diagnose OA, a doctor will check the individual’s medical history, and conduct a physical exam and order X-rays.
There are steps concerned persons can take to reduce their risk of developing OA, including exercise and weight control. Currently, there is no cure for OA and there are a few medications on the market used to alleviate pain and reduce inflammation.
In San Antonio, Texas Diagnostics Research Group is conducting a study to evaluate the effects of an OA medication not available to the public. If interested parties have been diagnosed with OA or think they may have OA, they may be a candidate for this study. To be considered for the study, patients must be 40 or older, have knee or hip pain and have taken some sort of pain reliever for the past 20 out of 30 days to alleviate symptoms. Participants will receive study medication and will be examined by a board certified physician. They will also receive compensation for their time and travel.
Persons who are interested in participating in the upcoming osteoarthritis trial may contact Diagnostics Research Group at 210-692-7157 for more information.
<br>About the company:<br>Diagnostics Research Group, located in the South Texas Medical Center in San Antonio, Texas, is an independent clinical research site that performs research studies to test the safety and effectiveness of new drugs, treatments and medical devices.
Patients who volunteer for clinical studies are helping the advancement of medicine with no cost to the participants. Once enrolled in a study, the patient will receive compensation for time and travel. Free health screenings are also available, which include: allergy, blood pressure, blood sugar, breathing and cholesterol tests.
Those interested in volunteering for clinical trials can expect quality care from the staff at Diagnostics Research Group. Nine staff members are certified by the Association of Clinical Research Professionals.
Diagnostics Research Group has research experience with more than 200 studies, including allergy studies, asthma studies and COPD studies. Other several therapeutic areas include: cedar allergy, respiratory diseases, internal medicine, women’s health, vaccines and sleep disorders. For more information, please visit their website at http://www.dxrg.com.
Read the full story at http://www.prweb.com/releases/Cedar-Allergy/Clinical-Studies/prweb10692697.htm.
Copyright©2012 Vocus, Inc.
All rights reserved